Effect of PRL on MAPK activation: Negative regulatory role of the C- terminal part of the PRL receptor

Molecular and Cellular Endocrinology

Volumn 159, Issue 1-2, 2000, Pages 133-146

  Goupille, Olivier ^a   Barnier, Jean Vianney ^b   Guibert, Bernard ^b   Paly, Jacqueline ^a   Djiane, Jean ^a  

^a CEMAGREF   (France)

^b CNRS   (France)

Author keywords

MAPK Erk pathway; Phosphatases; PI3 kinase; Prolactin receptor; Tyrosine phosphorylation

Indexed keywords

ARSENOSOBENZENE; DIMETHYL SULFOXIDE; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PERVANADATE; PHOSPHATASE INHIBITOR; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; SERINE THREONINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME REGULATION; FEMALE; HORMONE RECEPTOR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SHEEP;

ANIMALS; CHO CELLS; CRICETINAE; ENZYME ACTIVATION; ENZYME INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROLACTIN; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE-PHOSPHATASE; RABBITS; RECEPTORS, PROLACTIN; SEQUENCE DELETION;

EID: 0033967439     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00197-5     Document Type: Article

References (80)

1. Al-Sakkaf K.A., Dobson P.R.M., Brown B.L. Activation of phosphatidyl 3-kinase by prolactin in Nb2 cells. Biochem. Biophys. Res. Commun. 221:1996;779-784.
2. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
3. Ali S., Chen Z., Lebrun J.J. et al. PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J. 15:1996;135-142.
4. Anderson N.G., Maller J.L., Tonks N.K., Sturgill T.W. Requirement for integration of signal from two distinct phosphorylation pathways for activation of MAP kinase. Nature. 343:1990;651-653.
5. Arcasoy M.O., Harris K.W., Forget B.G. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of JAK2 and STAT5 inactivation. Exp. Hematol. 27:1999;63-74.
6. Berlanga J.J., Gualillo O., Buteau H., Applanat M., Kelly P., Edery M. Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase. J. Biol. Chem. 272:1997a;2050-2052.
7. Berlanga J.J., Garcia-Ruiz J.P., Perrot-Applanat M., Kelly P.A., Edery M. The short form of the prolactin receptor silences prolactin induction of the β-casein gene promoter. Mol. Endocrinol. 11:1997b;1449-1457.
8. Bignon C., Daniel N., Kermabon A.Y., Djiane J. Prolactin induces growth inhibition and promotes differentiation of CHO cells stably transfected with prolactin receptor complementary DNA. FEBS Lett. 358:1995;84-88.
9. Buckley A.R., Rao Y., Buckley D.J., Gout P.W. Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cells. Biochem. Biophys. Res. Commun. 204:1994;1158-1164.
10. Camarillo I.G., LineBauch B.E., Rillema J.A. Differential tyrosyl-phosphorylation of multiple mitogen-activated protein kinase isoforms in response to prolactin in Nb2 lymphoma cells. Proc. Sci. Exp. Biol. Med. 215:1997;202.
11. Carey G.B., Liberti J.P. Stimulation of receptor-associated kinase, tyrosine kinase, and MAP kinase is required for prolactin-mediated macromolecular biosynthesis and mitogenesis in Nb2 lymphoma. Arch. Biochem. Biophys. 316:1995;179-189.
12. Chabre O., Cornillon F., Bottari S.P., Chambaz E.M., Vilgrain I. Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, adenosine 3′, 5′-monophosphate, and tyrosine kinase receptor pathways. Endocrinology. 136:1995;956-964.
13. Chang W., Clevenger C.V. Modulation of growth factor receptor function by isoform heterodimerization. Proc. Natl. Acad. Sci. USA. 93:1996;5947-5952.
14. Chang W., Ye Y., Clevenger C.V. Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras. Mol. Cell. Biol. 18:1998;896-905.
15. Charles C.H., Sun H., Lau L.F., Tonks N.K. The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 90:1993;5292-5296.
16. Clevenger C.V., Ngo W., Sokol D.L., Luger S.M., Gewirtz A.M. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J. Biol. Chem. 270:1995;13246-13253.
17. Clevenger C.V., Torigoe T., Reed J.C. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J. Biol. Chem. 270:1994;5559-5565.
18. Cohen P., Holmes C.F.B., Tsukitani Y. Okadaïc acid: a new probe for the study of cellular regulation. Trends Biochem. Sci. 15:1990;98-102.
19. Daniel N., Waters M.J., Bignon C., Djiane J. Involvement of a subset of tyrosine kinases and phosphatases in regulation of the β-lactoglobulin gene promoter by prolactin. Mol. Cell. Endocrinol. 118:1996;25-35.
20. Das R., Vonderhaar B.K. Tranduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol. Endocrinol. 9:1995;1750-1759.
21. Das R., Vonderhaar B.K. Activation of Raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res. Treat. 40:1996a;141-149.
22. Das R., Vonderhaar B. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene. 13:1996b;1139-1145.
23. Das R., Vonderhaar B.K. Prolactin as mitogen in mammary cells. J. Mammary Gland Neoplast. 2:1997;29-39.
24. DaSilva L., Rui H., Erwin R.A. et al. Prolactin recruits STAT1, STAT3, and STAT5 independent of conserved receptor tyrosines TYR402, TYR476, TYR515 and TYR580. Mol. Cell. Endocrinol. 177:1996;131-140.
25. David M., Petricoin D., Benjamin C., Pine R., Weber M.J., Larner A.C. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science. 269:1995;1721-1723.
26. Dong F., Liu X., de Koning J.P. et al. Stimulation of STAT5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J. of Immunol. 161:1998;6503-6509.
27. Duckworth B.C., Cantley L.C. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. J. Biol. Chem. 272:1997;27665-27670.
28. Erwin R.A., Kirken R.A., Malabarba M.G., Farrar W.L., Rui H. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology. 136:1995;3512-3518.
29. Gadina M., Stancato L.M., Bacon C.M., Larner A., O'Shea J.J. Involvement of SHP-2 in multiple aspects of Il-2 signaling: evidence for a positive regulatory role. J. of Immunol. 160:1998;4657-4661.
30. Garcia-Morales P., Minami Y., Luong E., Klausner R.D., Samelson L.E. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc. Natl. Acad. Sci. USA. 87:1990;9255-9259.
31. Gasser F., Mulsant P., Gillois M. Long-term multiplication of the Chinese hamster ovary (CHO) cell line in a serum-free medium. In Vitro Cell Dev. Biol. 21:1985;588-592.
32. Gibbs V.C., Takahashi M., Aguet M., Chuntharapai A. A negative regulatory region in the intracellular domain of the human interferon-α receptor. J. Biol. Chem. 271:1996;28710-28716.
33. Goupille O., Daniel N., Bignon C., Jolivet G., Djiane J. Prolactin signal transduction to milk protein gene: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation. Mol. Cell. Endocrinol. 127:1997;155-169.
34. Hackett R.H., Wang Y., Sweitzer S., Feldman G., Wood W., Larner A. Mapping of the cytoplasmic domain of the human Growth Hormone Receptor that regulates rates of inactivation of JAK2 and STAT proteins. J. Biol. Chem. 272:1997;11128-11132.
35. Han Y., Kohanski R.A. Phenylarsine oxide inhibits Insulin activation of phosphatidylinositol 3′-kinase. Biochem. Biophys. Res. Commun. 239:1997;316-321.
36. Haneda M., Sugimoto T., Kikkawa R. Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. Eur. J. Pharmacol. 365:1999;1-7.
37. Hawes B.E., Luttrell L.M., van Biesen T., Lefkowitz R.J. Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271:1996;12133-12136.
38. Hill C.S., Treisman R. Transcriptional regulation by extracellular signals: mechanism and specificity. Cell. 80:1995;199-211.
39. Hodge C., Liao J., Stofega M., Guan K., Carter-Su C., Schwartz J. Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and jun-B through activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 273:1998;31327-31336.
40. Hunter M.G., Avalos B.R. Phosphatidylinositol 3′-kinase and sh2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-inhibitory domains in the granulocyte colony-stimulating factor receptor. J. Immunol. 160:1998;4979-4987.
41. Karnitz L.M., Burns L.A., Sutor S.L., Blenis J., Abraham R. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15:1995;3049-3057.
42. Kato Y., Sato H., Ichikawa M. Existence of two pathways for endocytosis of epidermal growth factor by rat liver: phenylarsine oxide-sensitive and -insensitive pathways. Proc. Natl. Acad. Sci. USA. 89:1992;8507-8511.
43. Kilgour E., Gout I., Anderson N.G. Requirement for phosphoinositide 3-OH kinase in growth hormone signaling to the mitogen-activated protein kinase and p70 S6K pathways. Biochem. J. 315:1996;517-522.
44. King W.G., Mattaliano M.D., Chan T.O., Tsichlis P.N., Brugge J.S. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17:1997;4406-4418.
45. Krautwald S., Büscher D., Kummer V., Buder S., Baccarini M. Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated proteins kinase pathway. Mol. Cell. Biol. 16:1996;5955-5963.
46. Kusari A.B., Byon J., Bandyopadhyay D., Kenner K., Kusari J. Insulin-induced mitogen-activated protein (MAP) kinase phosphatase 1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: a mechanism for the feedback inhibition of insulin signaling. Mol. Endocrinol. 11:1997;1532-1543.
47. Lannuzel A., Barnier J.V., Hery C. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann. Neurol. 42:1997;847-856.
48. Lesueur L., Edery M., Ali S., Paly J., Kelly P.A., Djiane J. Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc. Natl. Acad. Sci USA. 88:1991;824-828.
49. Lin T., Kong X., Saltiel A.R., Blackshear P.J., Lawrence J.C. Control of PHAS-I by insulin in 3T3-L1 adipocytes. J. Biol. Chem. 270:1995;18531-18538.
50. Liu Q., Oliviera-Dos-Santos A.J., Mariathasan S., Bouchard D., Jones J. et al. The Inositol polyphosphate 5-phosphatase ship is a crucial negative modulator of B cell antigen receptor signaling. J. Exp. Med. 188:1998;1333-1342.
51. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
52. Matsuguchi T., Lilly M.B., Kraft A.S. Cytoplasmic domains of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor β chain (hβc) responsible for human GM-CSF-induced myeloid cell differentiation. J. Biol. Chem. 273:1998;19411-19418.
53. Metzler B., Hu Y., Sturm G., Wick G., Xu Q. Induction of mitogen-activated kinase phosphatase-1 by arachidonic acid in vascular smooth muscle cells. J. Biol. Chem. 273:1998;33220-33326.
54. Millward T.A., Zolnierowicz S., Hemmings B.A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:1999;186-191.
55. Misra-Press A., Rim C.S., Yao H., Roberson M.S., Stork P.J.S. A novel mitogen-activated protein kinase phosphatase. J. Biol. Chem. 270:1995;14587-24596.
56. Möller C., Hansson A., Enberg B., Lobie P.E., Norstedt G. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J. Biol. Chem. 267:1992;23403-23408.
57. Noguchi T., Matozaki T., Horita K., Fujioka Y., Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src Homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell. Biol. 14:1994;6674-6682.
58. Nohara A., Ohmichi M., Koike K., Jikihara H. et al. Prolactin stimulates mitogen-activated protein kinase in human leiomyoma cells. Biochem. Bioph. Res. Commun. 238:1997;473-477.
59. Oh E., Gu H., Saxton T., Timms J.F., Hausdorff S. et al. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol. Cell. Biol. 19:1999;3205-3215.
60. Perrot-Applanat M., Gualillo O., Pezet A., Vincent V., Edery M., Kelly P.A. Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol. Endocrinol. 11:1997;1020-1032.
61. Pezet A., Ferrag F., Kelly P.A., Edery M. Tyrosine docking sites of the rat prolactin receptor required for association and activation of STAT5. J. Biol. Chem. 272:1997;25043-25050.
62. Piccoletti R., Maroni P., Bendilli P., Bernizelli-Zazzera A. Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J. 303:1994;429-433.
63. Rameh L.E., Chen C., Cantley L.C. Phosphatidylinositol (3, 4, 5)P3 interacts with SH2 domains and modulates PI3-kinase association with tyrosine-phosphorylated proteins. Cell. 83:1995;821-830.
64. Rao Y., Buckley D.J., Buckley A.R. Rapid activation of mitogen-activated protein kinase and p21 Ras by prolactin and interleukin-2 in rat Nb2 node lymphoma cells. Cell growth Differ. 6:1995;1235-1244.
65. Ratovondrahona D., Fournier B., Odessa M.F., Dufy B. Prolactin stimulation of phosphoinositide metabolism in CHO cells stably expressing the PRL receptor. Biochem. Bioph. Res. Commun. 243:1998;127-130.
66. Scimeca J.C., Servant M.J., Dyer J., Meloche S. Essential role of calcium in the regulation of MAP kinase phosphatase-1 expression. Oncogene. 15:1997;717-725.
67. Sharenberg A.M., Kinet J.P. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell. 87:1996;961-964.
68. Shi Z., Lu W., Feng G. The Shp-2 tyrosine phosphatase has opposite effect in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J. Biol. Chem. 273:1998;4904-4908.
69. Sonoda Y., Kasahara T., Yamaguchi Y., Kuno K., Matsushima K., Mukaida N. Stimulation of interleukin-8 production by okadaïc acid and vanadate in a human promyelocyte cell line, an HL-60 sub-line: possible role of mitogen-activated protein kinase on the okadaïc acid-induced NF-kappa B activation. J. Biol. Chem. 272:1997;15366-15372.
70. Sorin B., Goupille O., Vacher A.M., Paly J., Djiane J., Vacher P. Distinct cytoplasmic regions of the prolactin receptor are required for prolactin-induced calcium entry. J. Biol. Chem. 273:1998;28461-28469.
71. Sun H., Charles C.H., Tonks N.K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAPK kinase in vivo. Cell. 75:1993;487-493.
72. Ui M., Okada T., Hazeki K., Hazeki O. Wortmannin as unique probe for intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20:1995;303-307.
73. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
74. Wartmann M., Cella N., Hofer P. et al. Lactogenic hormone activation of STAT5 and transcription of the β-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity. J. Biol. Chem. 271:1996;31863-31868.
75. Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
76. Winston L.A., Hunter T. Intracellular signaling: putting JAKs on the kinase MAP. Curr. Biol. 6:1996;668-671.
77. Winston L.A., Hunter T. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270:1995;30837-30840.
78. Yamashita H., Xu J., Erwin R., Farrar W., Kirken R.A., Rui H. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of STAT5a and Ser730 of STAT5b in prolactin-sensitive cells. J. Biol. Chem. 273:1998;30218-30224.
79. Yamauchi T., Kaburagi Y., Ueki K., Tsuji Y., Stark G.R., Kerr I.M. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, -3, their association with p85 Phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J. Biol. Chem. 273:1998;15719-15726.
80. Yamauchi T., Ueki K., Tobe K., Tamemoto H., Sekine N. Tyrosine phosphorylation of the EGF receptor by the kinase JAK2 is induced by growth hormone. Nature. 390:1997;91-96.